Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Baricitinib may effectively treat lichen planopilaris.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Upadacitinib improved multiple immune-related conditions in one patient.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Treat active lichen planopilaris early to prevent permanent hair loss.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Polydeoxyribonucleotides may help with healing and anti-aging, but more research is needed.

Certain medications can cause serious side effects, so it's important to report them.